Articles Mentioning Life Sciences Tools and Services Stocks

Results 41 - 50 of 418 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | December 03, 2014

Why Sequenom, Inc. Stock Skyrocketed

Sequenom splices and dices its ways to huge gains after announcing the settlement of a long-standing patent dispute with a rival.

Investing | October 24, 2014

Pacific Biosciences of California Earnings Rocket Higher on Roche Deal

What investors need to know about Pacific Biosciences' third quarter performance.

Investing | October 23, 2014

3 Reasons Thermo Fisher Scientific Inc.'s Stock Could Rise

Thermo Fisher Scientific's future rests on three pillars of growth, and a big-name acquisition may tip the scales in their favor.

Investing | September 29, 2014

3 Reasons Illumina, Inc.'s Stock Could Fall

Illumina (ILMN) seems unbeatable in sequencing today, but tomorrow could bring changes no one can anticipate.

Investing | September 23, 2014

3 Reasons Illumina, Inc.'s Stock Could Rise

It's the leader in a fast-growing young industry, but does Illumina (ILMN) have what it takes to trounce the market over the long term?

Investing | June 30, 2014

Why Are Companion Diagnostics So Important?

Patients, doctors, and investors have been excited about new frontiers in oncology, but can these drugs be useful without companion diagnostics?

Investing | June 24, 2014

Will Danaher Corporation Bounce Back With a Big Buyout?

M&A's been the biggest trend of health care in 2014, but Danaher's been notably quiet. Will this acquisitions king jump into the game this year?

Investing | April 24, 2014

Illumina, Inc.: How the Market's Smartest Company is Living Up to the Hype

Illumina won rave reviews for its innovative technology after making the $1,000 genome possible, but the company showed off its financial prowess in the first quarter.

Investing | April 23, 2014

Illumina Inc's Seemingly Endless Victory Lap

It's harder to call Illumina overpriced when it continues to surpass bullish expectations and build its lead on rivals

Investing | March 28, 2014

4 Disruptive Stocks Biotechs Depend On

Contract research organizations Quintiles (Q), Icon PLC (ICLR), Covance (CVD), and Parexel (PRXL) are redefining how biopharma discovers and develops new therapies.

Results 41 - 50 of 418 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services